MedPath

Eealy Improvement Predicts Antidepressants Response in Adults With Major Depression Disorder

Conditions
Major Depressive Disorder
Interventions
Registration Number
NCT03230682
Lead Sponsor
Huashan Hospital
Brief Summary

Early improvemrnt, decreased 20% in the 17 items of Hamilton Depression Rating Scale (HAMD-17) at the second week of the treatment of major depression disorder (MDD), can arguably predict the remission at the 12th week. Our observation study including 80 MDD patients will access resting-state function MRI to finding factors which infuencing early improvemrnt, respone and remission of antidepressants.

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
80
Inclusion Criteria
  • right-handed; HAMD-17 more than 17; diagnosed with MDD by the Structured Clinical Interview for DSM-IV
Exclusion Criteria
  • patients diagnosed with other condition in DSM-IV Axis I; pregnency; Thyroid disease; Heart Disease

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
major depressive disorderantidepressant-
Primary Outcome Measures
NameTimeMethod
Early improvementthe second week of treatment

obtain 20% decrease of HAMD-17

Secondary Outcome Measures
NameTimeMethod
Responsethe 12th week of treatment

obtain 50% decrease of HAMD-17

Trial Locations

Locations (1)

Dept. of Neurology, Huashan Hospital, Fudan University

🇨🇳

Shanghai, Shanghai, China

© Copyright 2025. All Rights Reserved by MedPath